PRESS RELEASE published on 10/29/2024 at 11:46, 1 year 10 months ago Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF published on 10/28/2024 at 12:31, 1 year 10 months ago Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
BRIEF published on 10/28/2024 at 12:31, 1 year 10 months ago Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
PRESS RELEASE published on 10/28/2024 at 12:26, 1 year 10 months ago Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF published on 10/25/2024 at 16:05, 1 year 10 months ago Pentixapharm Holding AG Announces Leadership Changes Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF published on 10/25/2024 at 16:05, 1 year 10 months ago Pentixapharm Holding AG annonce des changements au sein de sa direction Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE published on 10/25/2024 at 16:00, 1 year 10 months ago Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF published on 10/19/2024 at 12:33, 1 year 11 months ago Pentixapharm's CXCR4 Compound Showcased at EANM Conference Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF published on 10/19/2024 at 12:33, 1 year 11 months ago Le composé CXCR4 de Pentixapharm présenté à la conférence EANM Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique
PRESS RELEASE published on 10/19/2024 at 12:28, 1 year 11 months ago Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM) Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress
Published on 09/24/2026 at 08:00, 58 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/23/2026 at 22:00, 10 hours 58 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 14 hours 33 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 17 hours 16 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 18 hours 27 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/24/2026 at 08:45, 13 minutes ago Huawei Unveils Six Global Power Showcases, Unlocking a New Power System with AI-Energy Synergy
Published on 09/24/2026 at 08:30, 28 minutes ago cyan AG publishes half year report 2026 – Growth trajectory and strategic expansion continued
Published on 09/24/2026 at 08:20, 38 minutes ago Pantum Technology Showcases New Printing Solutions at IFA 2026, Expanding European Market Strategy
Published on 09/24/2026 at 08:00, 58 minutes ago Policy Address by Hong Kong SAR’s Chief Executive John Lee: Deepening Reforms and Leveraging Strengths for a Brighter Future
Published on 09/24/2026 at 08:00, 58 minutes ago Neoen launches construction of 3 solar farms and a wind farm in France, with a total capacity of 101 MW
Published on 09/24/2026 at 08:00, 58 minutes ago Neoen lance la construction de trois parcs solaires et un parc éolien en France pour une capacité totale de 101 MW
Published on 09/24/2026 at 07:30, 1 hour 28 minutes ago Gimv rondt met succes private plaatsing van een obligatie af voor een bedrag van EUR 150 miljoen
Published on 09/24/2026 at 07:30, 1 hour 28 minutes ago Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Published on 09/24/2026 at 07:30, 1 hour 28 minutes ago Gimv successfully completes private placement of a bond for an amount of EUR 150 million